lung adenocarcinoma | GenomeWeb

lung adenocarcinoma

The software takes somatic mutation profiles from individual patients as input and uses them to prioritize relevant mutations and potential treatments.

Exome sequences and copy number patterns suggest lung adenocarcinoma and squamous cell carcinoma are each marked by specific somatic mutations and driver genes.

The consortium will analyze data from patients and mouse models in the first year as part of efforts to find ways of detecting tumors earlier.

The firm presented data from a study that explored how the lung cancer gene expression test changes prognostic risk classifications compared to pathological factors.

In Genome Biology this week: intra-tumor heterogeneity assessed with single-cell RNA sequencing, common epigenetic alterations in tumors, and more.

In Genome Biology this week: investigation of host expression and microbial communities in pouchitis, liver fluke genome sequencing, and more.

Led by former LabCorp executives, the firm is aiming to develop evidence around genetic signatures and license the tech to labs and Dx developers.

NEW YORK (GenomeWeb) – Researchers from the Massachusetts Institute of Technology this month reported new animal data showing that an endothelial cell-targeting nanoparticle can carry microRNAs and siRNAs into lung tumors and cause the cancer to regress.

NEW YORK (GenomeWeb) – Members of the Cancer Genome Atlas today described driver mutations and potential drug targets detected in a common form of lung cancer called lung adenocarcinoma.

NEW YORK (GenomeWeb News) – An international team of researchers led by Robert Plenge from Brigham and Women's Hospital uncovered nearly four dozen loci linked to risk of rheumatoid arthritis, bringing the total number of known risk loci for the disease to 101.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.